---
# Documentation: https://wowchemy.com/docs/managing-content/

title: TCERG1L allelic variation is associated with cisplatin-induced hearing loss
  in childhood cancer, a PanCareLIFE study
subtitle: ''
summary: ''
authors:
- A. J. M. Meijer
- F. A. Diepstraten
- T. Langer
- L. Broer
- I. K. Domingo
- E. Clemens
- A. G. Uitterlinden
- A. C. H. de Vries
- M. van Grotel
- W. P. Vermeij
- R. A. Ozinga
- H. Binder
- J. Byrne
- E. van Dulmen-den Broeder
- M. L. Garre
- D. Grabow
- P. Kaatsch
- M. Kaiser
- L. Kenborg
- J. F. Winther
- C. Rechnitzer
- H. Hasle
- T. Kepak
- K. Kepakova
- W. J. E. Tissing
- A. L. F. van der Kooi
- L. C. M. Kremer
- J. Kruseova
- S. M. F. Pluijm
- C. E. Kuehni
- H. J. H. van der Pal
- R. Parfitt
- C. Spix
- A. Tillmanns
- D. Deuster
- P. Matulat
- G. Calaminus
- A. E. Hoetink
- S. Elsner
- J. Gebauer
- R. Haupt
- H. Lackner
- C. Blattmann
- S. J. C. M. M. Neggers
- S. R. Rassekh
- G. E. B. Wright
- B. Brooks
- A. P. Nagtegaal
- B. I. Drogemoller
- C. J. D. Ross
- A. P. Bhavsar
- A. G. Am Zehnhoff-Dinnesen
- B. C. Carleton
- O. Zolk
- M. M. van den Heuvel-Eibrink
- PanCareLIFE Consortium
- CPNDS Consortium
tags: []
categories: []
date: '2021-07-01'
lastmod: 2022-12-11T16:52:44-06:00
featured: false
draft: false

# Featured image
# To use, add an image named `featured.jpg/png` to your page's folder.
# Focal points: Smart, Center, TopLeft, Top, TopRight, Left, Right, BottomLeft, Bottom, BottomRight.
image:
  caption: ''
  focal_point: ''
  preview_only: false

# Projects (optional).
#   Associate this post with one or more of your projects.
#   Simply enter your project's folder or file name without extension.
#   E.g. `projects = ["internal-project"]` references `content/project/deep-learning/index.md`.
#   Otherwise, set `projects = []`.
projects: []
publishDate: '2022-12-11T22:52:43.140883Z'
publication_types:
- '2'
abstract: 'In children with cancer, the heterogeneity in ototoxicity occurrence after
  similar treatment suggests a role for genetic susceptibility. Using a genome-wide
  association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893507)
  to be associated with hearing loss in 390 non-cranial irradiated, cisplatin-treated
  children with cancer. These results were replicated in two independent, similarly
  treated cohorts (n = 192 and 188, respectively) (combined cohort: P= 5.3 x 10(-10),
  OR 3.11, 95% CI 2.2-4.5). Modulating TCERG1L expression in cultured human cells
  revealed significantly altered cellular responses to cisplatin-induced cytokine
  secretion and toxicity. These results contribute to insights into the genetic and
  pathophysiological basis of cisplatin-induced ototoxicity.'
publication: '*NPJ PRECISION ONCOLOGY*'
doi: 10.1038/s41698-021-00178-z
---
